Cases & Deals

TxCell implements two-year equity line with Société Générale

Clients TxCell SA

Jones Day advised TxCell SA, a biotech company specializing in innovative, personalized cell-based immunotherapies, in connection with the implementation of a two-year equity line with Société Générale.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.